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Animals show different behaviors that can consist of various spatially or temporally separated sub-
reactions. Even less complex organisms, like ciliated larvae that display important behaviors (e.g. 
metamorphosis, defense, feeding), need to coordinate coherent sub-reactions with their simple nervous 
system. These behaviors can be triggered by neuropeptides, which are short signaling peptides. Despite 
the high diversity of neuropeptides in animals, and although their immunoreactivity is widely used in 
morphological studies of animal nervous systems (e.g. FMRFamide), their function and role in trochozoan 
larval behavior has so far only been tested in a few cases. When mechanically disturbed, the planktonic 
larvae of the brachiopod Terebratalia transversa protrude their stiff and pointy chaetae in a defensive 
manner and sink down slowly: a startle reaction that is known from different chaetous trochozoan larvae. 
We found that both of these reactions can be induced simultaneously by the FMRFamide-related 
neuropeptide FLRFamide. We deorphanized the Terebratalia FLRFamide receptor and found its 
expression spatially separated in the apical lobe at the prototroch of the larvae and in the trunk 
musculature, which correlates with the tissues that are responsible to perform the two sub-reactions. A 
behavioral assay showed a decreasing efficiency of modified peptides in triggering this behavior, which 
correlates with the decreasing efficiency of activating the FLRFamide receptor in transfected CHO-K1 
cells. Immunohistochemistry and in situ hybridization show FLRFamidergic neurons in the apical lobe as 
well as next to the trunk musculature. Our results show that the single neuropeptide FLRFamide can 
specifically induce the two coherent sub-reactions of the T. transversa startle behavior. 
 
Introduction 
Planktonic organisms evolved different strategies to defend themselves from predation [1-4]. 
Morphological characters like shells, spines or chaetae [5-7] and behaviors such as vertical migration, 
contraction, active fleeing or passive sinking [8-11] can help to cope with certain predators. This is 
especially true for ciliated larvae that do not possess an elaborated nervous system and face the 
challenge of remaining in the water column for dispersal while avoiding predation. The startle behavior of 
several planktonic annelid and brachiopod larvae has often been described as a major defense strategy, 
where they stop swimming and protrude long and pointy chaetae [12-16]. The co-occurring sub-reactions 
of spreading the chaetae and stopping swimming take place in spatially separated tissues: the internal 
trunk musculature and the ciliated apical edge, respectively. Both sub-reactions have to be coordinated 
within the framework of a larval nervous system. One mechanism to achieve coordination of different 
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reactions could be the use of neuropeptides as signaling molecules. Neuropeptides are known to 
influence many behaviors and can be crucial in the regulation and coordination of spatially or temporally 
separated coherent sub-reactions. During insect ecdysis for example, the eclosion hormone and the 
ecdysis-triggering hormone act both as a form of master-regulator on different peripheral as well as 
central targets, and each coordinates several sub-reactions [17-20]. Another example is neuropeptide Y 
which stimulates appetitive as well as consummatory ingestive behavior in the Siberian hamster [21].  In 
Platynereis dumerilii, myoinhibitory peptide first triggers settlement of the non-feeding larvae and later in 
development stimulates food intake in juveniles [22, 23].  
Only a few studies have demonstrated the influence of neuropeptides on the behavior of trochozoan 
larvae: these studies show that neuropeptides can trigger settlement and influence their ciliary based 
locomotion [22, 24-26]. One of the neuropeptides that has been shown to influence ciliary beating of 
different trochozoan larvae is FMRFamide [24-26]. FMRFamide-immunoreactivity is widely used as a 
marker for neural substructures in morphological studies [27, 28]. Furthermore, while FMRFamide related 
peptides (FaRPs) have been identified in many metazoans, their phylogenetic relationship is difficult to 
reconstruct [29-31]. For the comparison of larval nervous systems it is therefore of crucial interest to 
understand the functional role of a neuropeptide and its versatility to trigger larval behaviors. 
While experimental studies in trochozoan larvae are limited, the physiological effect of FMRFamide has 
been intensively investigated in adult trochozoans were it showed to have various muscular effects [32-
36]. Depending on the species, it can increase or decrease the heartbeat [32], cause contractions or 
relaxation of somatic muscles [33-35] or change the efficiency of classical neurotransmitters on somatic 
muscles [37, 38]. So far only one study has shown a muscular effect of FMRFamide in larvae, which 
describes a twitching of the ciliated velum of Tritia obsoleta larvae [24]. Many immunohistochemical 
analyses on trochozoan larvae show FMRFamide-like immuno-reactivity associated with muscles or 
ciliary bands [39-41] but experimental data are mostly missing.  
Since neuropeptides can act over longer distances [42], the localization of the neuropeptide receptor 
provides more information about the actually effected tissues than the peptide secreting cells that are 
labeled with the peptide antibodies. The majority of neuropeptide receptors are G-protein coupled 
receptors (GPCRs), with a few exceptions like insulin receptors or peptide gated ion channels [30, 43, 
44]. For FMRFamide, there have been three different receptors deorphanized in invertebrates so far. One 
is an FMRFamide-gated amiloride-sensitive Na+ channel (FaNaCh) that has been identified in molluscs 
[45-47]. The two other receptors belong to two different groups of neuropeptide GPCRs. One of these 
FMRFamide-GPCRs was identified in the fruit fly Drosophila melanogaster [48, 49] and the other one in 
the annelid P. dumerilii [44]. This stands in contrast to many cases in which homologues ligands activate 
homologues receptors [44, 50, 51].  
Here we show that the endogenous FaRP FLRFamide induces the characteristic defense behavior in the 
larvae of the brachiopod Terebratalia transversa, which consists of a downward sinking and the 
protrusion of their chaetae. Behavioral experiments and receptor deorphanization in combination with 
immunohistochemistry and in situ hybridization show that both coherent sub-reactions are specifically 
triggered by a single peptide via an ancient FaRP receptor. Together our results show how a single 
neuropeptide can trigger two coherent reactions and integrate evolutionary novelties such as trochozoan 
chaetae [52] into the T. transversa larval defense behavior. 
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Material and Methods 
Collection and rearing of Terebratalia transversa larvae 
Adult T. transversa (Sowerby, 1846) were collected in January by dredging in approximately 50-100 
meter depth close to University of Washington’s Friday Harbor Laboratories, San Juan Islands. Larvae 
were obtained according to [53] by artificial fertilization and kept at 8-10°C. We used early larvae (2 days 
post fertilization) before chaetal formation and late larvae (4-5 days post fertilization) with clearly 
developed mantle lobes and long chaetae. For immunohistochemistry and in situ hybridization, larvae 
were relaxed in 7.8% MgCl2-6H2O for 10-15 min, fixed in 4% methanol-free formaldehyde in seawater for 
1h, subsequently washed in PBS + 0.1% Tween and transferred into 100% methanol for storage at -20°C. 
 
Bioinformatics 
The previously published transcriptome of T. transversa (Accession: SRX1307070) was queried for 
peptide precursor and receptor candidates using BLAST. For reference sequences, we used published 
FMRFamide like peptide precursor sequences from NCBI and checked candidates for signal peptides, 
cleavage sites and amidation sites. As reference sequences for the peptide receptor we used previously 
published collections [30, 44] and included transcriptomes of Xenoturbella bocki (Accession: 
SRX1343818), Nemertoderma westbladi (Accession: SRX1343819), Meara stichopi (Accession: 
SRX1343814) and Halicryptus spinulosus (Accession: SRX1343820) for additional sequences. The 
candidates were compared using the software CLANS [54] with a p-value cutoff of 1e-70. Sequences that 
were strongly connected in the cluster map were aligned with Clustal X v.2.1 [55], unconserved stretches 
were deleted manually and the best fitting amino acid substitution matrix was determined with 
Modelgenerator v.0.85 [56]. The final phylogenetic analysis was calculated with PhyML v3.0 [57] with 500 
bootstrap replicates and visualized with Figtree v1.4.3 (http://tree.bio.ed.ac.uk/software/figtree). 
 
Behavioral assay 
We tested synthetic peptides (GenScript) that were predicted from the prepropetide sequence and 
compared the reaction with non-native modifications of those. 
To determine the efficiency of the native and modified peptides we tested at which concentration larvae 
contracted and spread their chaetae. To get an estimation of the peptide concentration that was 
necessary to induce a complete contraction we exposed larvae to a concentration of 50 nmol/l of the 
respective peptide and increased the concentration stepwise until the larvae contracted or a concentration 
of 50 μmol/l was reached as an upper cutoff. Larvae were considered fully contracted when their chaetae 
were spread in all directions (fig.1 C). In addition to this, they did not further increase in contraction 
following an increase in peptide concentration, or followed by the use of the most sensitive peptide. Using 
this approximate concentration, we then tested fixed concentrations to narrow down the sensitivity 
window. Each test was performed with 30-100 larvae. 
The vertical swimming experiments were recorded in 4.5 ml cuvettes with 50-100 larvae per cuvette, in a 
darkened box with top-illumination. About 1 minute after addition of the peptide in the treatments and 
water/DMSO in the controls we recorded the larval swimming (DMK 31AU03 camera, Imaging Source). 
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All experiments were repeated with at least one different batch of larvae from another fertilization and the 
outcome was averaged afterwards. 
 
Receptor deorphanization 
For deorphanization we followed the procedure used by [44]: Full length ORFs of receptor candidate 
sequences were cloned into pcDNA3.1(+) mammalian expression vector (Sigma-Aldrich) and transfected 
into CHO-K1 cells together with a calcium sensitive luminescent apoaequorin-GFP fusion protein 
encoding plasmid (G5A) and a promiscuous Gα-16 protein encoding plasmid. After two days, 
coelenterazine h (Promega, Madison, WI, USA) was added and incubated with the cells for two hours. 
The luminescence response of the transfected cells was measured in a plate reader (BioTek Synergy Mx 
or Synergy H4, BioTek, Winooski, USA) over 45 seconds after addition of the neuropeptides. The 
response of the cells to 1 mM Histamine was used as a general control in each plate. All measurements 
for the dose response curves were made twice with different cell passages. Dose response curves were 
calculated using Prism 6 (GraphPad, La Jolla, USA) and normalized against the upper plateau values 
(100% activation). 
 
In situ hybridization 
FLRFamide precursor and receptor sequences were amplified by PCR and cloned into pGEM Teasy 
vector (Promega) for in vitro transcription of DIG-UTP or DNP-UTP labeled RNA probes. For Tropomyosin 
we used a previously published clone [58]. The in situ hybridization protocol with an alternative 
hybridization buffer will be published elsewhere (Sinigaglia et al. 2017 - unpublished). In general we 
followed the protocol from [59] with following adjustments: Proteinase K treatment (10 μg/ml) was 
adjusted to 8 minutes and the following postfixation was done in 3.7% Formaldehyde + 0.2% 
Glutaraldehyde in PBS + 0.1% Tween 20. The hybridization buffer contained 4 mol/l Urea, 5x SSC, 1% 
Dextran, 1% SDS, 50 μg/ml Heparin, 50 μg/ml single stranded DNA and no Formamide. The signal was 
developed with the TSA Plus Cy3 or Cy5 kit (Perkin Elmer) or NBT/BCIP as a substrate and detected via 
fluorescence or NBT/BCIP reflection [60] in a Leica SP5 confocal laser-scanning microscope.  
 
Immunohistochemistry 
Customized polyclonal antibodies were raised in rabbits against CFLRFamide, coupled via a disulfide 
bridge to Keyhole limpet hemocyanin (GenScript®). Co-staining was either done with mouse anti-
acetylated α-tubulin (Sigma, T6793) or mouse anti-actin (Seven Hills Bioreagents, LMAB-C4) antibodies. 
For immuno-staining we followed the protocol of [61] with the following adjustments: Proteinase K 
treatment (10 μg/ml) was done for 3-5 minutes and after the proteinase inactivation step with glycine (2 
mg/ml) the samples were incubated for 2-4h in PBS + 0.5% TritonX. Primary antibodies were incubated 
over 3 nights at 4°C and washed for 4-6 hours with at least 10 changes of washing medium. Secondary 
antibodies were incubated over night and included a secondary antibody without primary partner (goat 
anti rat) to test and subtract unspecific background staining. After washing the secondary antibodies for 4-
6 hours with at least 10 changes of buffer, specimens were transferred into methanol and mounted in 
Murray’s clear (2:1 parts benzyl-benzoate : benzyl-alcohol). 
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Results 
The endogenous neuropeptide FLRFamide triggers the defense behavior of T. 
transversa larvae 
During normal swimming the chaetae of competent T. transversa larvae rest against their pedicle lobe 
with their tips forming a bundle (fig.1 A). When the larvae get disturbed (e.g. mechanical irritation with a 
pipette tip) they stop swimming, sink down slowly and exhibit a defensive stance by lengthwise 
contraction of their body to spread the 4 bundles of chaetae outwards (fig.1 B,C,E). At maximal 
contraction the larvae spread their chaetae likewise in all directions to surround their soft body (fig.1 C,E).  
 
Fig.1: Defense reaction and FLRFamide prepropeptide of the T. transversa larvae. A-C sketch, D-E 
SEM photographs , anterior up, F sketch. A larva in relaxed stance during normal swimming; B non 
contracted larva that begins to spread its chaetae; C larva in defense stance with outspread chaetae; D 
non-contracted competent larva; E contracted competent larva with outspread chaetae. F schematic 
representation of T. transversa FLRFamide prepropeptide. al anterior lobe, ml mantle lobe, pl pedicle 
lobe, vm ciliated ventral mid line. Scale bar: 50 μm 
 
We discovered a FLRFamide prepropeptide sequence in the transcriptome of T. transversa. The 
FLRFamide precursor contains a signal peptide, three copies of DFLRFamide and five copies of 
AFLRFamide, partially separated by intermediate sequences (fig.1 F). When we exposed larvae to 
synthetic FLRFamide, they contracted lengthwise, spread out their chaetae and sank down slowly. Both 
predicted peptides, DFLRFamide and AFLRFamide, caused the same behavior. When exposed to 50 
nmol/l DFLRFamide all larvae showed initial signs of contraction, indicated by their chaetae bundles being 
slightly fanned out while still pointing in a posterior direction (fig.1 B,D). About half of the larvae continued 
swimming while the other half started to sink slowly on the bottom. An increase in peptide concentrations 
lead to an overall increase in contraction, resulting in a stronger spreading of the chaetae and more 
larvae sinking down. A maximum contraction of all larvae, with their body being completely surrounded by 
chaetae was observed at concentrations of 500-750 nmol/l DFLRFamide. When we removed the peptides 
by exchanging the medium with fresh seawater, all larvae returned to normal swimming behavior. 
Continuous exposure for about 2 hours led to a desensitization and the larvae resumed normal swimming 
without removing the peptides. When the larvae were desensitized by continuous exposure to 
DFLRFamide, they became also insensitive to AFLRFamide and vice versa. 
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Taken together we found T. transversa larvae show a continuing behavior which is similar to their startle 
response when we exposed them to one of the neuropeptides encoded on the endogenously expressed 
FLRFamide precursor. 
 
FLRFamide causes sinking of larvae independent from the protrusion of their chaetae 
One part of the defense behavior of T. transversa larvae is a slow downward sinking. This reaction can 
already be observed in early larvae (sFig.1 E) before they develop long chaetae. Due to the shape of the 
larvae and the lack of a clearly restricted prototroch it was not possible to directly record the ciliary 
beating. However, since their larval locomotion is purely driven by ciliary beating, we hypothesize that 
FLRFamide influences the ciliary movement. To measure the swimming behavior in an unbiased manner, 
we recorded the position of freely swimming larvae in vertical columns and compared it to the position of 
larvae after exposure to DFLRFamide (fig.2 A). To test the possibility that the sinking is caused by an 
increase in the water drag due to the protruded chaetae, we also recorded early larva that do not have 
long chaetae yet but already express FLRFamide in the apical lobe (sFig.1 D). Both stages showed a 
sinking behavior that shifted the distribution of the larvae in the water column down, compared to the 
controls (fig.2 B).  
 
Fig.2: Influence of FLRFamide on the vertical distribution of early and late larvae. A Schematic 
experimental setup to compare the vertical distribution of larvae under different conditions in parallel. B 
Vertical distribution of early and late larvae in the water column and the effect of 5 μmol/l DFLRFamide. 
Red bar shows average level of swimming height, p values are calculated for difference in distribution of 
larvae in upper versus lower half of the column (2-tailed, unpaired t-test), blue line is the estimated trend 
line (not statistically supported). Distribution was measured over a period of 5 seconds, about 1 minute 
after exposure to peptide. 
 
Modified peptides trigger the defense behavior at different concentration thresholds 
We tested at which concentration modified peptides induce the contraction that leads to the erection of 
the chaetae, with 50 μmol/l as a cutoff for the maximum concentration (tab.1, sTab.1 ). The larvae were 
most sensitive to DFLRFamide and showed full contraction (fig.1 C,E), sinking and very slow movement 
on the bottom of the dish at concentrations between 500 nmol/l and 750 nmol/l (batch dependent). 
Further increasing the concentration did not lead to an obvious increase in the reaction. AFLRFamide 
showed to be slightly less effective by triggering full contraction of all larvae between 1 and 1.5 μmol/l. 
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The reduced peptide sequence FLRFamide showed to be effective at 3 μmol/l. Changing the amidated C-
terminal phenylalanine to an amidated tryptophan reduced the effectiveness by about 10-fold, with a 
minimum necessary concentration of 7.5 μmol/l of DFLRWamide or 20 μmol/l of AFLRWamide. Changing 
the C-terminal phenylalanine to the non-aromatic leucine only led to a very weak contraction in some of 
the larvae at 50 μmol/l DFLRLamide (fig.1 B) whereas 50 μmol/l AFLRLamide gave no reaction at all. 
Reducing the sequence to the three C-terminal amino acids LRFamide also didn’t lead to any contraction; 
neither did any of the other non-related peptides that we tested. (The full list of tested peptides is given in 
sTab.01). The overall most effective versions were the ones that are encoded on the pro-peptide 
sequence, DFLRFamide and AFLRFamide. The reduced peptide FLRFamide was slightly less effective 
and a modification of the amidated C-terminus reduced the effectiveness even more. 
 
Tab.1: Necessary peptide concentrations to evoke larval defense stance 
compared to EC50 values of receptor activation. 
peptide 
necessary concentration to 
induce full contraction 
EC50 receptor assay 
DFLRFamide 0.625 μmol/l 11.2 nmol/l 
AFLRFamide 1.5 μmol/l 12.4 nmol/l 
FLRFamide 3 μmol/l 33.2 nmol/l 
DFLRWamide 8.75 μmol/l 0.9 μmol/l 
 
Identification of the T. transversa FaRP receptor 
Based on BLAST e-value similarities and cluster analysis we tested four receptor candidates for their 
activation by FLRFamide (fig.3 A). One candidate belongs to a cluster of receptors that includes the 
deorphanized P. dumerilii FMRFamide receptor [44] with related sequences in all major bilaterian groups 
including Xenacoelomorpha (fig.3 A "I"). The second candidate belongs to the luqin receptors (fig.3 A "II"). 
The third candidate belongs to a group of related receptors with unknown ligand (fig.3 A "III") and the 
fourth one belongs to a group that shows similarities with the deorphanized Drosophila melanogaster 
FMRFamide and the P. dumerilii NKY receptors (fig.3 A "IV"). Transcriptome searches for an FMRFamide 
gated ion channel (FaNaCh) as it was identified in molluscs did not reveal any orthologs in T. transversa, 
even when using FaNaCh orthologs that were identified in the brachiopods Lingula anatina and 
Novocrania anomala.  
To test whether FLRFamide is the ligand of one of these receptors, we tested their activation by 
DFLRFamide in transfected CHO-K1 cells. This first test showed that only the candidate that is related to 
the previously deorphanized P. dumerilii FMRFamide-receptor was activated by 1 μmol/l DFLRFamide 
but none of the other candidates. We called this GPCR the FLRFamide receptor. Since DFLRFamide 
already triggered the defense stance at concentrations below 1 μmol/l in the behavioral assay, we did not 
test the negative GPCR candidates at higher peptide doses. We further compared the luminescence 
response of FLRFamide receptor expressing CHO-K1 cells to 1 μmol/l DFLRFamide, AFLRFamide, 
FLRFamide, DFLRWamide and DFLRLamide (fig.4 A). The two native forms DFLRFamide and 
AFLRFamide lead to the highest luminescence, followed by FLRFamide in a similar range. DFLRWamide 
gave a strongly decreased luminescence and the values of DFLRLamide were barely higher than the 
negative control.  
Dose response curves were recorded for DFLRFamide, AFLRFamide, FLRFamide and DFLRWamide 
(fig.4 B) and EC50 values (half maximal effective concentration) were determined for each peptide.  
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Fig.3: Phylogeny of the T. transversa-FLRFamide receptor. A Clustermap of metazoan 
neuropeptide GPCRs that show connections to FMRFamide receptors. Connections correspond 
to blastp connection with p-values <1e-70. Groups that include the receptors I-IV that were 
tested for activation by FLRFamide are encircled. NPY neuropeptide Y, NPF neuropeptide F, 
PRL prolactin releasing peptide. B Cladogram of neuropeptide GPCRs that showed connections 
in the clustermap to the T. transversa FLRFamide receptor (I). The dashed lines indicate 
receptor groups related to the Terebratalia FLRFamide receptor. Branches with filled circle at 
the end indicate a receptor that was deorphanized in a previous study. 
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DFLRFamide and AFLRFamide showed EC50 values in a similar range (1.12E-08 and 1.24E-08 mol/l). 
The EC50 value for FLRFamide was about three times higher (3.32E-08 mol/l) and the one for 
DFLRWamide was the highest of all tested peptides (9.06E-07 mol/l). The EC50 values are listed in table 
1, together with the concentrations that were necessary to trigger the defense stance in the behavioral 
assay. 
 Fig.4: Luminescence response of T. transversa-FLRFamide receptor expressing CHO-K1 cells to 
different peptides. A Relative luminescence of T. transversa-FLRFamide receptor expressing cells after 
exposure to different peptides with a fixed concentration of 1 μmol/l. B Dose response curves of T. 
transversa-FLRFamide receptor expressing cells to different concentrations of DFLRFamide, 
AFLRFamide, FLRFamide and DFLRWamide. Luminescence values are given relative to maximum 
luminescence (max = 1). RLU relative luminescence. 
 
After we deorphanized the FLRFamide receptor, we tested its phylogenetic relationship to the receptors 
that showed connections in the cluster analysis (fig.3 A "I-III"). We did not include the unrelated T. 
transversa orphan receptor that is related to the insect FMRFamide and trochozoan NKY receptors (fig.3 
A "IV"). The T. transversa FLRFamide receptor is directly related the previously deorphanized P. dumerilii 
FMRFamide receptor and several orphan receptors of other trochozoan (fig.3 B). Orthologs to these 
trochozoan FMRFamide/FLRFamide receptors were found in the insect Nilaparvata lugens, the 
hemichordate Saccoglossus kowalevskii and the xenacoelomorph Meara stichopi. A third related group 
includes orphan receptors from the cephalochordate Branchiostoma floridae, the vertebrate Callorhinchus 
milii and the xeacoelomorphs M. stichopi and Nemertoderma westbladi, These receptors form a fully 
supported group of neuropeptide GPCRs with homologs in all major bilaterian clades that is well 
seperated from other neuropeptide GPCR groups. (Fig.3 B) 
Taken together we discovered that the T. transversa FLRFamide receptor belongs to an ancient 
neuropeptide receptor group and is efficiently activated by the two peptides AFLRFamide and 
DFLRFamide that are encoded on the T. transversa prepropeptide sequence. 
 
In Situ Hybridization and Immunohistochemistry show localization of peptide receptor in 
trunk musculature and apical prototroch region 
The FLRFamide precursor has several expression domains within the apical lobe around the neuropile, 
and two domains on the ventral side at the anterior border of the mantle lobe (fig.5 A,B,E; sFig.1 B,C). 
The number of domains in the apical lobe varied between three and five (fig.5 A,B) and each domain 
consists of approximately three to seven cells. The combined in situ hybridization with tropomyosin as a 
marker for the musculature shows that the FLRFamide precursor expression in the mantle lobe is 
adjacent to the ventral side of the trunk musculature (fig.5 E). The FLRFamide receptor is expressed in a 
left and a right stripe in the trunk musculature (fig.5 B,C; sFig.1 A) as well as in the musculature that 
projects and surrounds the chaetae sacs (fig.5 D; sFig.1 A). Apart from the expression in the musculature 
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the receptor is also expressed in the apical lobe in a broad stripe underneath the ciliated prototroch (fig.5 
B,C; sFig.1 A).  
 
Fig.5: In situ hybridization and immunostainings of Terebratalia-FLRFamide, Terebratalia-
FLRFamide receptor, musculature and tubulin. A-E in situ hybridization; F-I immunohistochemistry; A-
D,G,J front view; E,F,H,I side view, ventral side left. A FLRFa and tropomyosin expression, arrows show 
FLRFa expression in mantle lobe. B FLRFa and FLRFa receptor expression, arrows show FLRFa 
expression in mantle lobe. C FLRFa receptor expression, stars show expression underneath prototroch. 
D tropomyosin and FLRFa receptor co-expression around chaetae sacks. E FLRFa and tropomyosin 
expression. F FLRFa and tubulin staining, star shows branching of FLRFa positive nerves inside ventral 
trunk area, arrows show branching of dorsal FLRFa positive trunk-nerve towards chaetae sacks. G 
FLRFa staining, stars show branching of FLRFa positive nerves inside dorsal trunk area, arrows show 
projections into secretory cells underneath the prototroch. H FLRFa and tubulin staining, arrows show 
nerve projecting from neuropil into ventral part of the trunk. I FLRFa and actin staining, arrows show lining 
of the musculature by FLRFamidergic nerves, projecting into mantle and posterior part of the trunk. J 
Schematic drawing of FLRFamidergic cells and nerves, FLRFa receptor and musculature. cs chaetae 
sacks, g gut, lc locomotory cilia of the prototroch, m musculature, np neuropil, r receptor, sc secretory 
cells, sv secretory vesicles. Color code is indicated at the bottom of the figure plate: Magenta FLRFamide 
(A,B,E precursor expression; F-I processed peptides), green FLRFamide-receptor, blue musculature 
(A,D,E tropomyosin expression; I actin staining), yellow nerve tracks and cilia. 
 
Since in situ hybridization only reveals were the peptide precursor is expressed, we used antibody 
staining to visualize the nerves that secrete the active peptides. The customized FLRFamide antibody 
revealed immuno-reactive longitudinal nerves that project from the apical neuropil (fig.5 F,G,H,I) pairwise 
along the ventral (fig. 7 H) and dorsal (fig. 7F) side into the trunk after branching off into the mantle 
towards the chaetae sacks at the border of the apical lobe and the mantle lobe (fig.5 F,H,I)). The nerves 
in the trunk are branching of strongly on the ventral side (fig.5 F,G) and are at least partially directly 
adjacent to the musculature (fig.5 I). The neuropile shows generally strong FLRFamide immunoreactivity 
with some nerves projecting towards the apical ciliary band and into the secretory cells that continue into 
secretory vesicles outside the apical lobe underneath the prototroch (fig.5 G,H,I). The secretory cells and 
vesicles themselves are prone to antibody trapping so no statement can be made whether they in fact 
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contain FLRFamide (compare fig.5 G without background subtraction and fig.5 F,H,I with background 
subtraction in secretory cells and secretory vesicles). 
 
Discussion 
FLRFamide triggers two coherent reactions via an ancient FaRP receptor  
The receptor deorphanization and phylogenetic analysis shows that the Terebratalia FLRFamide receptor 
belongs to the ancient FaRP-GPCR group with closely related trochozoan GPCRs that include the 
deorphanized P. dumerilii FMRFamide receptor [44] and related orphan GPCRs in all major bilaterian 
groups (fig.3).The comparable sensitivity to different peptide modifications of the larvae in the behavioral 
assay and the EC50 values of the receptor cell assay suggests that the larval response is triggered via the 
FLRFamide receptor. The expression of the FLRFamide receptor in the longitudinal trunk musculature 
and the musculature adjacent to the chaetae sacks in the mantle supports a direct mode of signaling 
whereby FLRFamide directly triggers the protrusion of the chaetae by inducing a muscle contraction. The 
expression of the receptor in a broad stripe underneath the ciliary band and the sinking of early and late 
larva, independent of the presence or absence of chaetae, also supports a direct effect of FLRFamide on 
the ciliated cells to induce the sinking behavior. While a direct influence of FMRFamide on the ciliary 
movement of trochozoan larvae has already been suggested before [25, 26], the combination of this 
reaction with the muscular contraction observed in the T. transversa larval startle response consists of 
two different behavioral actions.  
 
The advantage of coherent sub-reactions during T. transversa defense behavior and 
their control by a single peptide 
Neuropeptides are considered to be ancient signaling molecules that are used in complex as well as 
simple nervous systems and are even present in Placozoa that lack neurons entirely [30, 62]. There are a 
few examples of complex behaviors that involve coherent sub-reactions like insect ecdysis or feeding, 
which are known to deploy single neuropeptides to act on several targets as a form of master-regulator 
[17-21]. When a single neuropeptide controls the erection of chaetae and sinking, it might coordinate the 
startle reaction independent from a direct neuronal wiring between these two structures.  
While many zooplankton organisms escape potential predators by a sudden increase in velocity, some 
species have been observed to use passive sinking as an efficient escape strategy instead [3, 63]. 
Passive sinking seems efficient for slow animals to escape quicker predators such as copepods that do 
not detect their prey by vision but by sensing water disturbance [3, 11, 64]. It has been described that 
other brachiopod and annelid larvae seem to have a similar startle behavior as T. transversa [12-16]. 
Direct observations showed that tiny fishes spit out Sabellaria larvae with their spines erected [15] and 
experimental data showed that Sabellaria larvae with long chaetae have a higher survival rate compared 
to younger larvae without chaetae when exposed to different predators [14]. The combination of a passive 
sinking behavior while actively erecting chaetae might thus increase the chance to escape different 
predators when compared to either only showing sinking behavior or a protrusion of chaetae. 
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Our results demonstrate a case in which a single receptor-ligand pair can trigger two coherent reactions 
that integrate evolutionary novelties such as trochozoan chaetae [52] and ancient traits such as ciliary 
based locomotion [65] into the T. transversa larval startle behavior. 
 
FaRP receptor-ligand pair was redeployed several times during trochozoan evolution  
The conserved receptor ligand pair in P. dumerilii and T. transversa stands in contrast to the various 
actions that FMRFamide can have in trochozoans. Several studies on trochozoan larvae have shown that 
FMRFamide like immuno-reactive nerves can be associated with several structures in a single animal and 
often include a combination of the apical organ, ciliary bands and the musculature, which would suggest 
different regulatory roles [39-41, 66-68]. However, in this context it is important to mention that antibodies 
against FMRFamide strongly cross-react with other peptides ending in RFamide, even within the same 
specimen [69, 70]. Inter-species comparisons of such labeled neurons across larger evolutionary 
distances are thus problematic. The cross-reactivity of polyclonal FMRFamide antibodies has even led to 
the discovery of new peptides in the past [71, 72] and the C-terminal ending RFamide is part of many 
different neuropeptides [30, 70, 73, 74]. Only a few experimental studies exist on the effect of 
FMRFamide on trochozoan larvae and those focus on the regulation of the ciliary-based locomotion, 
which ultimately influences the vertical swimming direction [24-26]. In the veliger larvae of Tritia obsoleta 
it has been observed that FMRFamide induces twitching of the velum that results in ciliary arrests while 
contracted [24]. Many studies on adult trochozoans show diverse effects of FMRFamide on various 
muscles [33-36] and further taxon-specific functions such as osmoregulation [75], chromatophore 
expansion [76] or suppression of salivary gland activity [77]. Experiments on different adult bivalves 
showed a taxon specific up- or down regulation of the heartbeat by FMRFamide [32] and the experiments 
on trochozoan larvae showed a taxon specific up- or down regulation of the ciliary beating [24-26]. The 
various taxon specific effects and association with different tissues suggest that the FaRP receptor-ligand 
pair proved to be generally useful as a regulating signaling system and was likely redeployed several 
times during trochozoan evolution.  
 
Supporting material and data accession 
Sequences of the here newly described genes and accession numbers of published sequences that were 
used in this study are listed in the supplementary material. Pictures of chromogenic in situ hybridization 
and a SEM picture of an early larva are shown in sFig.1. A list of tested peptides is given in sTab.1. 
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sFig.1: FLRFamide peptide and receptor expression in T.transversa larvae. A-C late larvae, in situ 
hybridization. Arrows indicate expression domains. A FLRFamide receptor expression. B ventral 
FLRFamide expression between apical and mantle lobe. (Same specimen as in C, but with a focus on the 
ventral side.) C FLRFamide expression in apical lobe. D early larva with FLRFamide expression in apical 
lobe. E SEM picture of early larva. Scale bar = 30 μm. 
 
sTab.1: Peptide concentrations that lead to a contraction of the larvae 
peptide batch 1 batch 2 
DFLRFamide 500 nM for full contraction 750 nM for full contraction 
AFLRFamide 1 μM for full contraction 2 μM for full contraction 
FLRFamide 3 μM for full contraction 3 μM for full contraction 
DFLRWamide 7.5 μM for full contraction 10 μM for full contraction 
AFLRWamide 20 μM for full contraction 20 μM for full contraction 
DFLRYamide 50 μM for full contraction 50 μM for full contraction 
AFLRYamide weak contraction in about 50% of 
the larvae at 50 μM 
no reaction at 50 μM 
DFLRLamide weak contraction in about 50% of 
the larvae at 50 μM 
no reaction at 50 μM 
AFLRLamide no reaction at 50 μM no reaction at 50 μM 
LRFamide no reaction at 50 μM no reaction at 50 μM 
YMRFamide* 10 μM for full contraction 15 μM for full contraction 
No contraction was observed at up to 50 μmol/l of following peptides:  
WQGMKMWamide, FLYamide, MDPSQFGYGIamide, FIamide, TDKCVPVYamide, 
AAKAPSSSamide, NSDGLamide, LGamide, GWamide, RGWamide, YSLDGIGSGLIamide, 
QYMamide, CYLYDCINamide 
*YMRFamide is the presumed homolog of FLRFamide in the brachiopod Novocrania anomala. 
 







signal peptide - cleavage site - C-terminal amidation site - FLRFamide 
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Terebratalia transversa orphan neuropeptide GPCR, related to trochozoan NKY and 

















Accession numbers of neuropeptide receptor reference sequences (fig. 3) 
[Xboc.rna.tri.15475.1 Xenoturbella bocki, in transcriptome SRX1343818] [Nwes_Locus_45236.0_Transcript_1/0 
Nemertoderma westbladi, in transcriptome SRX1343819] [Msti.rna.tri.15359.1 Meara stichopi, in transcriptome 
SRX1343814] [Msti.rna.tri.31113.1 Meara stichopi, in transcriptome SRX1343814] [Msti.rna.tri.31092.1 Meara 
stichopi, in transcriptome SRX1343814] [Hspi_Locus_51813.1_Transcript_3/0 Halicryptus spinulosa, in transcriptome 
SRX1343820] [AKQ63075.1 Platynereis dumerilii, Luqin receptor, deorphanized] [AKQ63063.1 Platynereis dumerilii, 
FMRFamide receptor, deorphanized] [O44426 Lymnaea stagnalis, Luqin receptor, deorphanized] [P92045 Lymnaea 
stagnalis, Lymnokinin receptor, deorphanized] [P49146 Homo sapiens, Neuropeptide Y receptor type 2, 
deorphanized] [P97295 Mus musculus, Neuropeptide Y receptor type 2, deorphanized] [Q9ERC0 Rattus norvegicus, 
Neuropeptide Y/peptide YY-Y2 receptor, deorphanized] [P29371 Homo sapiens, Neuromedin-K receptor, 
deorphanized] [P47937 Mus musculus, Neuromedin-K receptor, deorphanized] [P16177 Rattus norvegicus, 
Neuromedin-K receptor, deorphanized] [FBpp0076853 Drosophila melanogaster, Leucokinin receptor, deorphanized] 
[FBpp0084470 Drosophila melanogaster, RYamide receptor, deorphanized] [FBpp0081791 Drosophila melanogaster, 
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Tachykinin receptor 1, deorphanized] [FBpp0084873 Drosophila melanogaster, Tachykinin receptor 2, deorphanized] 
[ELT88896 Capitella teleta ] [XP_009016737 Helobdella robusta ] [XP_009054576 Lottia gigantea ] [XP_009060043 
Lottia gigantea ] [XP_005090267 Aplysia californica] [EKC27293 Crassostrea gigas ] [XP_009027087 Helobdella 
robusta ] [XP_007899584 Callorhinchus milii] [XP_009054574 Lottia gigantea] [BAO01094 Nilaparvata lugens ] 
[XP_002730513 Saccoglossus kowalevskii ] [XP_002596257 Branchiostoma floridae ] [XP_002734699 Saccoglossus 
kowalevskii ] [XP_002738788 Saccoglossus kowalevskii ] [XP_002731479 Saccoglossus kowalevskii ] 
[XP_002742045 Saccoglossus kowalevskii ] [XP_002596255 Branchiostoma floridae ] [NP_001161681 Saccoglossus 
kowalevskii ] [XP_002732003 Saccoglossus kowalevskii ] [XP_006812800 Saccoglossus kowalevskii] 
[XP_009060304 Lottia gigantea ] [XP_003700723 Megachile rotundata ] [XP_002732001 Saccoglossus kowalevskii ] 
[NP_001161604 Saccoglossus kowalevskii ] [NP_001098693.1Takifugu rubripes] [XP_001342488.2 Danio rerio] 
[XP_009064591.1 Lottia gigantea ] [XP_009067028.1 Lottia gigantea ] [XP_009050865.1 Lottia gigantea ] 
[XP_009064514.1 Lottia gigantea ] [ELT99672.1 Capitella teleta ] [XP_009017792.1 Helobdella robusta ] 
[XP_009017796.1 Helobdella robusta ] [XP_009062052.1Lottia gigantea ] [XP_008498708 Calypte anna ] [Q1ACB1 
Oncorhynchus mykiss] [F1R5V3_DANRE Danio rerio] [E9HAW0_DAPPU Daphnia pulex] [G3X054_SARHA 
Sarcophilus harrisii] [G1NS97_MELGA Meleagris gallopavo] [J9JKR1_ACYPI Acyrthosiphon pisum] 
[B3XXN5_BOMMO Bombyx mori] [B4MM03_DROWI Drosophila willistoni] [K1PQW2_CRAGI Crassostrea gigas] 
[B3XXN2_BOMMO Bombyx mori] [H3ILX9_STRPU Strongylocentrotus purpuratus] [H3ILY0_STRPU 
Strongylocentrotus purpuratus] [H9K8U7_APIME Apis mellifera] [Q8VHD7_RAT Rattus norvegicus] [G1TPU6_RABIT 
Oryctolagus cuniculus] [K1Q8V2_CRAGI Crassostrea gigas] [D6WD17_TRICA Tribolium castaneum] 
[Q6AWE5_DROME Drosophila melanogaster] [I4IY86_TAKRU Takifugu rubripes] [F1R3V0_DANRE Danio rerio] 
[F7E6B1_MONDO Monodelphis domestica] [B4JUW2_DROGR Drosophila grimshawi] [Q94736_STOCA Stomoxys 
calcitrans] [E9FUQ7_DAPPU Daphnia pulex] [Q8T8D1_UREUN Tachykinin receptor] 
 
